Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Acquired factor XIII deficiency: A review.

Yan MTS, Rydz N, Goodyear D, Sholzberg M.

Transfus Apher Sci. 2018 Dec;57(6):724-730. doi: 10.1016/j.transci.2018.10.013. Epub 2018 Oct 30. Review.

PMID:
30446212
2.

Choroid Plexus Papilloma and Factor XIII Deficiency: Case Report.

Aydin Ozturk P, Sanri O, Yilmaz A, Arpa A, Ozturk U, Ceviz A.

Pediatr Neurosurg. 2018;53(6):413-415. doi: 10.1159/000492334. Epub 2018 Sep 3.

PMID:
30176663
3.

Identification of a novel nonsense mutation leading to congenital factor XIII deficiency.

Li B, Borhany M, Abid M, Kohler HP, Schroeder V.

Thromb Res. 2018 May;165:83-85. doi: 10.1016/j.thromres.2018.03.019. Epub 2018 Mar 27. No abstract available.

PMID:
29604433
4.

Pathogenicity analysis of variations and prenatal diagnosis in a hereditary coagulation factor XIII deficiency family.

Sun L, Yan Q, Wang Y, Luo H, Du P, Hassan R, Liu L, Jiang W.

Hematology. 2018 Sep;23(8):501-509. doi: 10.1080/10245332.2017.1422315. Epub 2018 Jan 7.

PMID:
29307277
5.

Molecular diagnosis of factor XIII deficiency, data from comprehensive coagulation laboratory in Iran.

Gheidishahran M, Dorgalaleh A, Tabibian S, Shams M, Sanei Moghaddam E, Khosravi S, Naderi M, Kahraze S, Lotfi F, Kazeme A, Safa M.

Blood Coagul Fibrinolysis. 2018 Jan;29(1):87-91. doi: 10.1097/MBC.0000000000000679.

PMID:
29095761
6.

A large case series on surgical outcomes in congenital factor XIII deficiency patients in Iran.

Naderi M, Haghpanah S, Miri-Aliabad G, Tavosi H, Karimi M.

J Thromb Haemost. 2017 Dec;15(12):2300-2305. doi: 10.1111/jth.13872. Epub 2017 Nov 1.

PMID:
29028293
7.

Factor XIII deficiency diagnosis: Challenges and tools.

Karimi M, Peyvandi F, Naderi M, Shapiro A.

Int J Lab Hematol. 2018 Feb;40(1):3-11. doi: 10.1111/ijlh.12756. Epub 2017 Oct 13. Review.

8.

Minimal factor XIII activity level to prevent major spontaneous bleeds: reply.

Menegatti M, Palla R, Bucciarelli P, Peyvandi F.

J Thromb Haemost. 2017 Nov;15(11):2280-2282. doi: 10.1111/jth.13851. Epub 2017 Oct 9. No abstract available.

PMID:
28926188
9.

Minimal factor XIII activity level to prevent major spontaneous bleeds: comment.

Dorgalaleh A, Tabibian SH, Safa M, Shams M, Naderi M.

J Thromb Haemost. 2017 Nov;15(11):2279-2280. doi: 10.1111/jth.13841. Epub 2017 Oct 9. No abstract available.

PMID:
28871658
10.

Assessment of Factor XIII.

Muszbek L, Katona É, Kerényi A.

Methods Mol Biol. 2017;1646:277-293. doi: 10.1007/978-1-4939-7196-1_22.

PMID:
28804836
11.

Lobar Hemorrhage Induced by Acquired Factor XIII Deficiency in a Patient with Cerebral Amyloid Angiopathy.

Arishima H, Neishi H, Kikuta KI, Morita M, Hosono N, Yamauchi T, Souri M, Ichinose A.

J Stroke Cerebrovasc Dis. 2017 Oct;26(10):e203-e205. doi: 10.1016/j.jstrokecerebrovasdis.2017.07.009. Epub 2017 Aug 8.

PMID:
28801214
12.

Clinical influence of preoperative factor XIII activity in patients undergoing pancreatoduodenectomy.

Watanabe N, Yokoyama Y, Ebata T, Sugawara G, Igami T, Mizuno T, Yamaguchi J, Nagino M.

HPB (Oxford). 2017 Nov;19(11):972-977. doi: 10.1016/j.hpb.2017.07.002. Epub 2017 Jul 17.

13.

Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure.

Rabik CA, Atkinson MA, Sule S, Strouse JJ.

Transfusion. 2017 Sep;57(9):2159-2163. doi: 10.1111/trf.14185. Epub 2017 Jul 13.

PMID:
28707410
14.

Factor XIII deficiency in south of Tunisia.

Maaloul I, Medhaffer M, Louhichi N, Krichen I, Alibi S, Kmiha S, Aloulou H, Fakhfakh F, Elloumi M, Kallel C, Hachicha M.

Blood Coagul Fibrinolysis. 2017 Sep;28(6):485-489. doi: 10.1097/MBC.0000000000000649.

PMID:
28704210
15.

Minimal factor XIII activity level to prevent major spontaneous bleeds.

Menegatti M, Palla R, Boscarino M, Bucciarelli P, Muszbek L, Katona E, Makris M, Peyvandi F; PRO-RBDD study group.

J Thromb Haemost. 2017 Sep;15(9):1728-1736. doi: 10.1111/jth.13772. Epub 2017 Aug 17.

16.

The first case report of a patient with acquired factor XIII deficiency in the context of autoimmune encephalitis.

Soto I, Bernardo A, Arias T, Ramón C, Noval I, Palomo C.

Haemophilia. 2017 Sep;23(5):e461-e464. doi: 10.1111/hae.13281. Epub 2017 Jun 29. No abstract available.

PMID:
28664679
17.

Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results.

Kerlin BA, Inbal A, Will A, Williams M, Garly ML, Jacobsen L, Kearney SL.

J Thromb Haemost. 2017 Aug;15(8):1601-1606. doi: 10.1111/jth.13748. Epub 2017 Jul 10.

PMID:
28581691
18.

Comparison of F13A1 gene mutations in 73 patients treated with recombinant FXIII-A2.

Ivaškevičius V, Biswas A, Garly ML, Oldenburg J.

Haemophilia. 2017 May;23(3):e194-e203. doi: 10.1111/hae.13233.

PMID:
28520207
19.

Defective α2 antiplasmin cross-linking and thrombus stability in a case of acquired factor XIII deficiency.

Mitchell JL, Wright S, Kazi S, Watson HG, Mutch NJ.

Br J Haematol. 2017 Sep;178(5):794-799. doi: 10.1111/bjh.14759. Epub 2017 May 17.

PMID:
28516512
20.

Supplemental Content

Loading ...
Support Center